Profil was founded in 1999 by a team of physicians, scientists, and clinical research associates who had been performing clinical trials at the WHO Collaborating Center for Diabetes at Heinrich-Heine University of Dusseldorf, Germany. The Institute has played a key role in the development of diabetic therapies and devices for all major global pharmaceutical companies. Profil allows pharmaceutical companies to achieve the competitive advantage. It manages your trials from start to finish while providing high-level consultation, including expert assistance in scientific validation and protocol planning.